APA (7th ed.) Citation

Tamai, T., Hayato, S., Hojo, S., Suzuki, T., Okusaka, T., Ikeda, K., & Kumada, H. (2017). Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses. Journal of clinical pharmacology, 57(9), 1138-1147. https://doi.org/10.1002/jcph.917

Chicago Style (17th ed.) Citation

Tamai, Toshiyuki, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, and Hiromitsu Kumada. "Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses." Journal of Clinical Pharmacology 57, no. 9 (2017): 1138-1147. https://doi.org/10.1002/jcph.917.

MLA (9th ed.) Citation

Tamai, Toshiyuki, et al. "Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses." Journal of Clinical Pharmacology, vol. 57, no. 9, 2017, pp. 1138-1147, https://doi.org/10.1002/jcph.917.